Wockhardt Exits US Generics Pharma Business To Focus On Innovation-Driven Areas; Details Here
Published on: July 11, 2025, 5:57 p.m. | Source: News18
Wockhardt says its US generics business has been loss-making for several years, incurring a loss of nearly $8 million in FY25 alone.
